HK1202416A1 - Compositions and methods for preventing and treating oral diseases - Google Patents

Compositions and methods for preventing and treating oral diseases

Info

Publication number
HK1202416A1
HK1202416A1 HK15102383.4A HK15102383A HK1202416A1 HK 1202416 A1 HK1202416 A1 HK 1202416A1 HK 15102383 A HK15102383 A HK 15102383A HK 1202416 A1 HK1202416 A1 HK 1202416A1
Authority
HK
Hong Kong
Prior art keywords
compositions
preventing
methods
oral diseases
treating oral
Prior art date
Application number
HK15102383.4A
Other languages
English (en)
Chinese (zh)
Inventor
Karen Lovetri
Srinivasa Madhyastha
Nandadeva Yakandawala
Purushottam V Gawande
Gord Froehlich
Original Assignee
Kane Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kane Biotech Inc filed Critical Kane Biotech Inc
Publication of HK1202416A1 publication Critical patent/HK1202416A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15102383.4A 2011-10-31 2015-03-09 Compositions and methods for preventing and treating oral diseases HK1202416A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161553506P 2011-10-31 2011-10-31
US201261641503P 2012-05-02 2012-05-02
US201261654490P 2012-06-01 2012-06-01
PCT/CA2012/050432 WO2013063695A1 (en) 2011-10-31 2012-06-27 Compositions and methods for preventing and treating oral diseases

Publications (1)

Publication Number Publication Date
HK1202416A1 true HK1202416A1 (en) 2015-10-02

Family

ID=48191147

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102383.4A HK1202416A1 (en) 2011-10-31 2015-03-09 Compositions and methods for preventing and treating oral diseases

Country Status (9)

Country Link
US (2) US11090366B2 (de)
EP (1) EP2773369B1 (de)
JP (1) JP6038167B2 (de)
CN (1) CN104010653B (de)
AU (1) AU2012332014B2 (de)
BR (1) BR112014010299A2 (de)
CA (1) CA2853857C (de)
HK (1) HK1202416A1 (de)
WO (1) WO2013063695A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2684150C (en) 2007-05-14 2016-10-04 Research Foundation Of State University Of New York Decenoic acid dispersion inducers in the treatment of biofilms
US11723852B2 (en) 2011-10-31 2023-08-15 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US11103433B2 (en) * 2012-06-27 2021-08-31 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
WO2014134731A1 (en) * 2013-03-07 2014-09-12 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
CN103432576B (zh) * 2013-09-09 2014-08-20 华中农业大学 卵黏蛋白液体制剂及其制备方法
CN115177607A (zh) 2013-09-24 2022-10-14 密歇根大学董事会 用于破坏生物膜稳定性、改变生物膜和分散生物膜的组合物和方法
WO2015099754A1 (en) 2013-12-27 2015-07-02 Colgate-Palmolive Company Prebiotic oral care compositions containing carboxylic acids
JP6440954B2 (ja) * 2014-03-18 2018-12-19 サンスター株式会社 オーラルケア組成物
CA2972397A1 (en) * 2014-10-08 2016-04-14 Nrl Pharma, Inc. Inhibitor of extracellular trap formation in leukocyte
KR20180016347A (ko) * 2015-04-13 2018-02-14 파운테인 테크놀로지스 인터내셔널, 엘엘씨 초-소형 지질 구조체의 생산을 위한 단일-단계 방법
CN105169375A (zh) * 2015-08-21 2015-12-23 吕欢 一种防治儿童蛀牙的复方含片
US11628136B2 (en) 2015-12-17 2023-04-18 Colgate-Palmolive Company Oral care compositions comprising at least one phosphate/acrylate copolymer and at least one cationic active ingredient
WO2017195135A1 (en) * 2016-05-11 2017-11-16 Nestec Sa Compositions and methods for reducing or preventing dental calculus accumulation in companion animals
CN106729649B (zh) * 2016-12-22 2020-11-10 江山 一种治疗口干症的口腔护理组合物及其应用
WO2018201119A1 (en) 2017-04-29 2018-11-01 Nevada Naturals Inc. Biofilm penetrating compositions and methods
FR3071729A1 (fr) * 2017-10-04 2019-04-05 Cementic Ciments dentaires desinfectants comprenant des liposomes
CN108186384A (zh) * 2018-01-24 2018-06-22 深圳市芭格美生物科技有限公司 一种漱口水及其制备方法
JP6580735B2 (ja) * 2018-03-16 2019-09-25 サンスター株式会社 オーラルケア組成物
US11052053B2 (en) 2018-05-08 2021-07-06 Evonik Operations Gmbh Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN111138524B (zh) * 2018-11-02 2023-07-07 武汉禾元生物科技股份有限公司 一种从基因工程水稻种子中分离纯化低铁饱和度的重组人乳铁蛋白的方法
IT201900004599A1 (it) * 2019-03-27 2020-09-27 Microbo Srl Formulazioni topiche orali e/o orali sistemiche contenenti una miscela a base di lattoferrina, più efficace nella captazione del ferro, per la prevenzione e trattamento di varie patologie
KR102090592B1 (ko) * 2019-11-15 2020-03-18 (주)제노랩 치석 방지용 구강 조성물
DE202020102037U1 (de) 2020-04-14 2020-04-22 Dot Gmbh Kupferhaltige Wasserlösliche Zusammensetzung
CN113662699B (zh) * 2021-04-24 2022-04-29 北京航空航天大学 一种基于霍尔效应的牙周袋深度测量装置
CN113975294B (zh) * 2021-11-04 2022-06-28 首都医科大学附属北京口腔医院 根管内消毒药物及其制备方法
CN116270266A (zh) * 2023-03-01 2023-06-23 杭州纳美智康科技有限公司 含锌化合物与过氧化氢结合在去口腔异味产品中的应用
CN117122564B (zh) * 2023-09-26 2024-05-14 海南卓科制药有限公司 一种氟尿嘧啶注射液及其制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060600A (en) 1972-10-26 1977-11-29 National Patent Development Corporation Treating teeth
US3887712A (en) 1973-06-15 1975-06-03 Merck & Co Inc Oral hygiene products
GB1524325A (en) 1976-03-18 1978-09-13 Ferrosan Ab Piperidine derivatives
US4160821A (en) 1978-02-27 1979-07-10 Johnson & Johnson Treatment for gingivitis
US4178363A (en) 1978-05-09 1979-12-11 Miller Taylor C Jr Method for reducing dental plaque and pellicle precursor of plaque
US4999184A (en) 1982-06-22 1991-03-12 The Procter & Gamble Company Oral compositions
US4610871A (en) 1984-12-21 1986-09-09 Ici Americas Inc. Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5174990A (en) * 1990-02-07 1992-12-29 7-L Corporation Mouthrinse and method of preparation
US5310546A (en) * 1990-02-07 1994-05-10 7-L Corporation Mouthrinse and method of preparation
US5104644A (en) * 1990-02-07 1992-04-14 7-L Corporation Mouthrinse composition
ZA94438B (en) * 1993-02-19 1994-08-29 Warner Lambert Co Pre-brushing rinse composition
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US5932469A (en) 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
US6475771B1 (en) 1997-06-10 2002-11-05 University Of Florida Research Foundation Antimicrobial polypeptides and methods of use
US6218362B1 (en) 1997-09-08 2001-04-17 Universite Laval Lantibiotic from Streptococcus mutans and uses thereof
US6342385B1 (en) 2000-07-28 2002-01-29 The Uab Research Foundation Mutacin I biosynthesis genes and proteins
US6589562B1 (en) 2000-10-25 2003-07-08 Salvona L.L.C. Multicomponent biodegradable bioadhesive controlled release system for oral care products
US7597895B2 (en) 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
US6696047B2 (en) 2001-09-13 2004-02-24 The Procter & Gamble Company Stable oral care compositions comprising chlorite
US6602490B1 (en) * 2002-03-04 2003-08-05 Richard A. Cloonan Dental cleaning formulation and manufacturing process
JP2005139201A (ja) * 2002-11-19 2005-06-02 Showa Yakuhin Kako Kk 歯石及びウ蝕部溶解剤
ES2214135B1 (es) * 2003-02-21 2005-05-01 Laboratorios Kin S.A. Composicion para el tratamiento de la cavidad bucal y utilizaciones correspondientes.
US20050101605A1 (en) * 2003-11-07 2005-05-12 Ahmed Salah U. Oral liquid formulations of methotrexate
US20050170013A1 (en) 2004-02-04 2005-08-04 Douglas Jerry A. Composition for treating a dermatological inflammatory response and method of preparation thereof
US20060134020A1 (en) * 2004-12-21 2006-06-22 Robinson Richard S Anti-caries oral care composition with a chelating agent
WO2006089139A2 (en) * 2005-02-15 2006-08-24 Lab39, Llc Oral care cleaning compositions and methods
WO2007076162A2 (en) 2005-12-29 2007-07-05 Kansas State University Research Foundation Antimicrobial cathelicidin peptides
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
US9072868B2 (en) 2008-10-27 2015-07-07 Pursuit Vascular, Inc. Device for delivery of antimicrobial agent into trans-dermal catheter
CN101756794A (zh) * 2008-11-18 2010-06-30 陈恩平 一种氯化锌防牙斑和牙龈炎的漱口水

Also Published As

Publication number Publication date
US11090366B2 (en) 2021-08-17
EP2773369A4 (de) 2015-09-23
JP2014532668A (ja) 2014-12-08
AU2012332014B2 (en) 2017-01-19
CN104010653B (zh) 2019-01-01
CA2853857C (en) 2022-06-14
US20150087582A1 (en) 2015-03-26
CN104010653A (zh) 2014-08-27
JP6038167B2 (ja) 2016-12-07
NZ624850A (en) 2016-10-28
EP2773369B1 (de) 2019-11-06
WO2013063695A1 (en) 2013-05-10
CA2853857A1 (en) 2013-05-10
BR112014010299A2 (pt) 2017-04-18
EP2773369A1 (de) 2014-09-10
US20210346470A1 (en) 2021-11-11
AU2012332014A1 (en) 2014-06-26

Similar Documents

Publication Publication Date Title
IL260585B (en) Preparations and methods for the treatment of diseases related to the retina of the eye
HK1202416A1 (en) Compositions and methods for preventing and treating oral diseases
EP2684167A4 (de) Zusammensetzungen und verfahren zur behandlung von erkrankungen
EP2655334A4 (de) Zusammensetzungen und verfahren zur behandlung von erkrankungen
HK1201475A1 (en) Methods and compositions for treating pain
ZA201305783B (en) Composition and methods for treating cardiovascular diseases
ZA201404187B (en) Compositions and methods for treating dental conditions
EP2771030A4 (de) Zusammensetzungen und verfahren zur behandlung von proteinopathien
EP2621588A4 (de) Verfahren und zusammensetzungen zur krankheitsbehandlung durch inhalation
EP2701742A4 (de) Zusammensetzungen und verfahren zur behandlung von autoimmunerkrankungen
EP2688594A4 (de) Verfahren und zusammensetzungen zur krebsbehandlung
DK3292875T3 (en) Compositions and methods for treating diseases
EP2691529A4 (de) Verfahren und zusammensetzungen zur behandlung von hirnerkrankungen
HK1202248A1 (en) Compositions and methods for treating neurodegenerative disease
EP2709614A4 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von krebs
HK1202246A1 (en) Compositions and methods for treating neurodegenerative disease
HK1243637A1 (zh) 順勢療法的治療方法及其組合物
SG11201400976WA (en) Methods and pharmaceutical compositions for treating cancer
ZA201207226B (en) Compositions and methods for treating viral diseases
SG11201402899TA (en) Methods and compositions for treating viral diseases
EP2801348A4 (de) Orale waschzusammensetzung zur vorbeugung und/oder behandlung von periodontopathien
EP2600864A4 (de) Zusammensetzungen und verfahren zur behandlung von entzündungskrankheiten
EP2714082A4 (de) Verbindungen und verfahren zur behandlung von schmerzen
EP2718427A4 (de) Zusammensetzungen und verfahren zur behandlung von glioblastomen
HK1199617A1 (en) Compositions and methods for treating viral diseases